Summit Therapeutics PLC
SMMT
$17.59+2.45%
End of day · as of Oct 10, 2026, 2:02 AM ET
Mkt cap
$11.46B
EV/Sales
N/A
P/E ratio
N/A
FY2024 Revenue
N/A
EPS (H1 2026)
$-0.52
Gross Margin (FY2024)
N/A
Profit Margin (FY2024)
N/A
Beta
-1.31
Div yield
N/A
Sector
Healthcare
Summit Therapeutics PLC (SMMT) is a biotechnology company listed on US.
Latest reported SMMT revenue for 2024-12-31 was $0. Net income was -$221.3M. SMMT currently screens at market cap $11.46B.
Use this SMMT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full SMMT income, balance, and cash tables.
Summit Therapeutics PLC (SMMT) is a biotechnology company in the Healthcare sector.
Latest cached Summit Therapeutics PLC (SMMT) net income for Dec 31, 2024 was -$221.3M. Statements: https://lician.com/financials/smmt
Summit Therapeutics PLC (SMMT) market capitalization is $11.46B on the latest cached snapshot.
Summit Therapeutics PLC (SMMT) cached previous close $17.17; day range $16.82 – $17.62; volume 5,746,763. Session quote: https://lician.com/quote/smmt
Summit Therapeutics PLC (SMMT) latest cached earnings event is "SMMT earnings" on Oct 19, 2026. Earnings calendar: https://lician.com/earnings
The latest cached SMMT filing is 8-K · Sep 29, 2026. Filings: https://lician.com/sec/smmt